Table 1.
FSH originator and biosimilars.
| Drug Name | Status | Originator |
|---|---|---|
| GONAL-f | Marketed | Merck |
| Cinnal-f | Marketed | CinnaGen |
| DA-3801 | Marketed | Dong-A Pharmaceutical |
| Bemfola | Marketed | Gedeon Richter |
| Ovaleap | Marketed | Theramex |
| Gonapure | Marketed | Minapharm Pharmaceuticals |
| Follitropin alpha biosimilar—Allergan/Itero Biopharmaceuticals | Phase III | Itero Biopharmaceuticals |
| LM-001 | Preclinical | Alphamab |
| Follitropin alpha biosimilar—Cadila Healthcare | Phase III | Cadila Healthcare |
| Folitime | No development reported | GEMA |
| Primapur | Phase III | iVFarma |
| ProLease | Discontinued | Merck Serono |
Data source: AdisInsight database—Springer. Available online at: https://adisinsight.springer.com (accessed on 1 March 2020).